ADVERTISEMENT

Cannabis

Tilray buys Breckenridge Distillery in move to grow U.S. business

If U.S. legalization happens there’s no reason why we couldn’t buy the rest of MedMen: Tilray CEO Irwin Simon, CEO and chairman of Tilray, joins BNN Bloomberg to discuss the company’s latest move to buy $165.8M worth of convertible bonds in MedMen. He notes this strategy will lead to a large share in the company and the possibility of buying MedMen later on.

TORONTO - Cannabis company Tilray Inc. says it has signed a deal to buy Breckenridge Distillery, a Colorado-based producer of whiskey and other spirits.

Financial terms of the agreement were not immediately available.

Founded in 2008, Tilray said the Breckenridge Distillery is known for its blended bourbon whiskey, a high-rye mash American-style whiskey.

Tilray already owns SweetWater Brewing Co. in the U.S.

The company said the Breckenridge deal helps grow its business with infrastructure and a larger footprint in the U.S. market where it hopes the federal government will ease its prohibitions on recreational cannabis.

It said once it becomes permissible it believes Breckenridge will help it develop non-alcoholic distilled spirits that are infused with cannabis.